When a company raises money, either an initial public offering or follow-up offering, the offering may include DRs. The inclusion of DRs may broaden the shareholder base of the company.

BNY Mellon collects fees from DR holders pursuant to the terms and conditions of the DRs and the deposit agreement under which they are issued. From time to time, BNY Mellon may make payments to the issuer to reimburse and / or share revenue from the fees collected from DR holders, or waive fees and expenses to the issuer for services provided, generally relating to costs and expenses arising out of establishment and maintenance of the DR program. BNY Mellon as depositary may use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

Ratio
DR:Ord
DR Price
Date
DR Price
(USD)
US / Non-US / Total DRs Placed US / Non-US / Total DR Captial Raised (USD) Pvtzn. Dep. Bank Industry Country Region
1:10000 Mar 29, 2024 .58 2,144,487
0
2,144,487
1,250,021
0
1,250,021
N BK Pharma. & Biotech. Israel Middle East/N. Africa/the Gulf
1:10000 Jan 25, 2024 .80 10,000,000
0
10,000,000
8,000,000
0
8,000,000
N BK Pharma. & Biotech. Israel Middle East/N. Africa/the Gulf
1:10000 Jul 21, 2023 1.35 1,084,923
0
1,084,923
1,464,646
0
1,464,646
N BK Pharma. & Biotech. Israel Middle East/N. Africa/the Gulf
1:10000 Mar 30, 2023 4.00 270,000
0
270,000
1,080,000
0
1,080,000
N BK Pharma. & Biotech. Israel Middle East/N. Africa/the Gulf
1:10000 Dec 02, 2022 .25 21,775,000
0
21,775,000
5,443,750
0
5,443,750
N BK Pharma. & Biotech. Israel Middle East/N. Africa/the Gulf
1:10000 May 09, 2022 1.42 5,059,708
0
5,059,708
7,184,785
0
7,184,785
N BK Pharma. & Biotech. Israel Middle East/N. Africa/the Gulf
1:10000 Nov 18, 2021 3.20 4,686,036
0
4,686,036
14,995,315
0
14,995,315
N BK Pharma. & Biotech. Israel Middle East/N. Africa/the Gulf
1:10000 Mar 01, 2021 8.00 4,647,433
0
4,647,433
37,179,464
0
37,179,464
-- BK Pharma. & Biotech. Israel Middle East/N. Africa/the Gulf
1:10000 Jan 11, 2021 7.84 3,188,776
0
3,188,776
25,000,004
0
25,000,004
-- BK Pharma. & Biotech. Israel Middle East/N. Africa/the Gulf
1:10000 Dec 06, 2018 7.00 2,857,143
0
2,857,143
20,000,001
0
20,000,001
N BK Pharma. & Biotech. Israel Middle East/N. Africa/the Gulf
1:10000 Aug 10, 2018 6.00 4,166,667
0
4,166,667
25,000,002
0
25,000,002
N BK Pharma. & Biotech. Israel Middle East/N. Africa/the Gulf
1:10000 Dec 29, 2016 10.25 266,208
0
266,208
2,728,632
0
2,728,632
-- BK Pharma. & Biotech. Israel Middle East/N. Africa/the Gulf
1:10000 Dec 27, 2016 10.25 3,713,415
0
3,713,415
38,062,504
0
38,062,504
N BK Pharma. & Biotech. Israel Middle East/N. Africa/the Gulf
1:10000 Jul 17, 2015 16.25 2,739,143
0
2,739,143
44,511,074
0
44,511,074
N BK Pharma. & Biotech. Israel Middle East/N. Africa/the Gulf
1:10000 Feb 13, 2015 12.50 1,150,000
0
1,150,000
14,375,000
0
14,375,000
N BK Pharma. & Biotech. Israel Middle East/N. Africa/the Gulf
1:10000 Jan 08, 2014 13.21 894,740
0
894,740
11,819,515
0
11,819,515
N BK Pharma. & Biotech. Israel Middle East/N. Africa/the Gulf

Powered by FactSet Research Systems Inc.